Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Conferences
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
15 Oct 2019 - 17 Oct 2019
3rd Annual Gene Therapy for Rare Disorders Europe, London (UK)
08 October 2019
GenSight Biologics to present new GS010 data at the 2019 Annual Meeting of the American Academy of Ophthalmology
09 Oct 2019
Future is now: Leaders in Ocular Gene Therapy Meeting, San Francisco (CA)
05 Sep 2019 - 08 Sep 2019
EURETINA 2019 Congress, Paris, France
26 Jun 2019 - 29 Jun 2019
UMDF Mitochondrial Medicine 2019, Washington DC, US
18 June 2019
GenSight Biologics announces presentation of results from the REVERSE Phase III trial of GS010 at the 14th meeting of the European Neuro-Ophthalmology Society (EUNOS)
16 Jun 2019 - 19 Jun 2019
14th Meeting of EUNOS, Porto, Portugal
13 Jun 2019 - 16 Jun 2019
2019 SOE Congress, European Society of Ophthalmology, Nice, France
03 Jun 2019 - 06 Jun 2019
BIO International Convention, Philadelphia, PA (US)
29 May 2019
Sustained bilateral improvement from GenSight Biologics’ REVERSE Phase III clinical trial represents transformative therapeutic benefit for patients, Key Opinion Leaders conclude
View previous 9 articles
1
…
3
4
5
6
7
8
9
10
11
12
View next 9 articles
Go back to the page of the page